Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR · NASDAQ Global Select
+$4.49 today
Vol 3.31M · Avg 1.82M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+427.53%
Period High
$81.82
Period Low
$14.71
Latest
$81.82
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Axsome Therapeutics, Inc.
NASDAQ:AXSM
$12.98B
Krystal Biotech, Inc.
NASDAQ:KRYS
$10.07B
TG Therapeutics, Inc.
NASDAQ:TGTX
$7.88B
Metsera, Inc.
MTSR
$7.43B
Alkermes plc
NASDAQ:ALKS
$7.42B
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.39B
Vaxcyte, Inc.
NASDAQ:PCVX
$7.32B
Arcellx, Inc.
ACLX
$6.73B
PTC Therapeutics, Inc.
NASDAQ:PTCT
$6.51B
CRISPR Therapeutics AG
NASDAQ:CRSP
$5.12B
What is the latest ARWR filing?
The latest filing shown is 3 dated Jun 17, 2026.
How many recent filings does ARWR have?
Intrinsic Alpha currently shows 20 recent filings for ARWR.
Explore More
Continue the stock analysis
Jump to another research area for this company.